Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC.

Nature. 1994 Mar 17;368(6468):215-21.

PMID:
8145819
2.

Cooperativity during the formation of peptide/MHC class II complexes.

Anderson MW, Gorski J.

Biochemistry. 2005 Apr 19;44(15):5617-24.

PMID:
15823020
3.

The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.

Ghosh P, Amaya M, Mellins E, Wiley DC.

Nature. 1995 Nov 30;378(6556):457-62.

PMID:
7477400
4.

Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1.

Zavala-Ruiz Z, Sundberg EJ, Stone JD, DeOliveira DB, Chan IC, Svendsen J, Mariuzza RA, Stern LJ.

J Biol Chem. 2003 Nov 7;278(45):44904-12. Epub 2003 Sep 1.

5.
6.

A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.

Zavala-Ruiz Z, Strug I, Anderson MW, Gorski J, Stern LJ.

Chem Biol. 2004 Oct;11(10):1395-402.

8.

Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.

Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Stauffacher C, Strominger JL, Wiley DC.

Nature. 1994 Apr 21;368(6473):711-8.

PMID:
8152483
9.
10.

MHC class II function preserved by low-affinity peptide interactions preceding stable binding.

Sadegh-Nasseri S, Stern LJ, Wiley DC, Germain RN.

Nature. 1994 Aug 25;370(6491):647-50.

PMID:
8065450
11.

Atomic structure of a human MHC molecule presenting an influenza virus peptide.

Silver ML, Guo HC, Strominger JL, Wiley DC.

Nature. 1992 Nov 26;360(6402):367-9.

PMID:
1448154
12.

A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.

Hülsmeyer M, Chames P, Hillig RC, Stanfield RL, Held G, Coulie PG, Alings C, Wille G, Saenger W, Uchanska-Ziegler B, Hoogenboom HR, Ziegler A.

J Biol Chem. 2005 Jan 28;280(4):2972-80. Epub 2004 Nov 10.

13.

Crystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II molecule.

Fernández MM, Guan R, Swaminathan CP, Malchiodi EL, Mariuzza RA.

J Biol Chem. 2006 Sep 1;281(35):25356-64. Epub 2006 Jul 6.

14.
15.

Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.

Xu M, Jackson R, Adams S, Humphreys RE.

Arzneimittelforschung. 1999 Sep;49(9):791-9.

PMID:
10514908
16.
18.
19.

Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition.

Brown LR, Nygard NR, Graham MB, Bono C, Braciale VL, Gorka J, Schwartz BD, Braciale TJ.

J Immunol. 1991 Oct 15;147(8):2677-84.

PMID:
1717572
20.

A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding.

Zarutskie JA, Sato AK, Rushe MM, Chan IC, Lomakin A, Benedek GB, Stern LJ.

Biochemistry. 1999 May 4;38(18):5878-87.

PMID:
10231540

Supplemental Content

Support Center